Improving addiction treatment and recovery strategies in New England.
Official title: CTN New England Consortium Node
Funded at Yale University · NIH-11302198 · Data updated 2026-11-12
This study is looking for ways to improve treatment and recovery for people dealing with opioid use disorder and other addictions, especially in African American communities, by testing new methods and medications to help them stay in treatment longer and feel better.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | March 1, 2025 |
| Project end | February 28, 2030 |
| Funding year | 2025 |
| Award (this year) | $7,024,272 |
| NIH project number | 3UG1DA015831-24S1 |
| Project ID | NIH-11302198 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals diagnosed with opioid use disorder or other substance use disorders, particularly those from African American communities.
✕Less likely to help
Patients who are not struggling with addiction or those who do not meet the specific criteria for the ongoing studies may not benefit from this research.
What this research studies
This research focuses on enhancing treatment and recovery strategies for individuals struggling with opioid use disorder (OUD) and other addictive disorders. It involves various ongoing studies that aim to optimize retention and treatment duration, assess the effectiveness of different medications, and evaluate outcomes in diverse community settings, particularly among African American populations. Patients may participate in trials that explore innovative approaches to addiction treatment, including remote follow-ups and integrated care models.
Why it matters
Potential benefit: If successful, this research could lead to more effective and accessible treatment options for individuals with addiction, improving recovery outcomes.
How similar studies have gone: Previous research has shown promising results in optimizing addiction treatment strategies, indicating that this approach has the potential for significant impact.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: D'onofrio, Gail — Yale University
- Study coordinator: D'onofrio, Gail
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.